Novo Holdings A/S’s Aerie Pharmaceuticals AERI Stock Holding History

Novo Holdings A/S’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-555,186	Closed	-$3.9M	–	54
2021 Q4	$3.9M	Hold	555,186	–	–	0.18%	47
2021 Q3	$6.33M	Hold	555,186	–	–	0.33%	40
2021 Q2	$8.89M	Sell	555,186 -233,224	-30%	-$4M	0.39%	39
2021 Q1	$14.1M	Sell	788,410 -19,246	-2%	-$332K	0.58%	31
2020 Q4	$10.9M	Hold	807,656	–	–	0.47%	35
2020 Q3	$9.51M	Hold	807,656	–	–	0.47%	30
2020 Q2	$11.9M	Buy	807,656 +56,682	+8%	+$838K	0.77%	21
2020 Q1	$10.1M	Buy	750,974 +80,938	+12%	+$1.54M	0.68%	14
2019 Q4	$16.2M	Hold	670,036	–	–	1.04%	13
2019 Q3	$12.9M	Buy	670,036 +100,000	+18%	+$2.29M	2.21%	11
2019 Q2	$16.8M	Buy	570,036 +119,322	+26%	+$4.6M	2.36%	10
2019 Q1	$21.4M	Hold	450,714	–	–	3.17%	7
2018 Q4	$16.3M	Buy	450,714 +42,152	+10%	+$1.98M	2.29%	9
2018 Q3	$25.1M	Buy	408,562 +282,165	+223%	+$18.1M	2%	6
2018 Q2	$8.54M	Buy	+126,397	New	+$7.07M	0.86%	16
2015 Q3	–	Sell	-100,000	Closed	-$1.76M	–	20
2015 Q2	$1.76M	Sell	100,000 -319,652	-76%	-$5.86M	0.13%	18
2015 Q1	$13.2M	Hold	419,652	–	–	1.12%	12
2014 Q4	$12.3M	Buy	+419,652	New	+$10.6M	0.99%	13

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Novo Holdings A/S's AERI Position: Q1 2022 in Review

Novo Holdings A/S sold out of Aerie Pharmaceuticals (AERI) in Q1 2022, closing a stake of 555,186 shares — an estimated $3.9M sold.

Novo Holdings A/S first reported a position in AERI in Q4 2014 and held it in 18 quarters. The position peaked at $25.1M in Q3 2018. 136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

Novo Holdings A/S reported no remaining Aerie Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Novo Holdings A/S sold 555,186 Aerie Pharmaceuticals shares in Q1 2022, an estimated $3.9M.
Novo Holdings A/S first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 18 quarters.
Novo Holdings A/S's Aerie Pharmaceuticals position peaked at $25.1M in Q3 2018.
136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on Novo Holdings A/S's 13F filing for Q1 2022, filed 16 May 2022.